康臣药业(01681)注销10万股已回购股份

Core Viewpoint - 康臣药业 announced the cancellation of 100,000 shares that were repurchased on February 12, 2026 [1] Company Summary - 康臣药业 is taking steps to manage its share capital by canceling repurchased shares, which may indicate a strategy to enhance shareholder value [1]